07:00 , May 9, 2016 |  BioCentury  |  Finance

ven and now

Strategic LPs once again dominate the second fund from venBio LLC, even though none of the first fund's M&A exits went to an LP. The firm's Global Strategic Fund II closed last week at $315...
08:00 , Feb 20, 2012 |  BC Week In Review  |  Company News

PPD supply/service news

CRO PPD partnered with NHS Research Scotland (NRS) to advance Scottish clinical research across therapeutic areas. PPD said it will work with the government to reduce study startup times, streamline regulatory approval processes, increase patient...
08:00 , Dec 12, 2011 |  BC Week In Review  |  Company News

PPD Inc. deal

Asset manager The Carlyle Group and private equity firm Hellman & Friedman completed their acquisition of CRO PPD for $33.25 per share in cash, or $3.9 billion (see BioCentury, Oct. 10). PPD Inc., Wilmington,...
08:00 , Nov 7, 2011 |  BC Week In Review  |  Company News

Emdeon Inc., The Blackstone Group deal

Investment firm Blackstone acquired healthcare IT provider Emdeon for $19 per share in cash, or about $3 billion. Private equity firm Hellman & Friedman will maintain a minority equity interest in Emdeon. Morgan Stanley and...
07:00 , Oct 10, 2011 |  BC Week In Review  |  Company News

PPD deal

Asset manager The Carlyle Group and private equity firm Hellman & Friedman will acquire CRO PPD for $33.25 per share in cash, or $3.9 billion. The price is a 30% premium to PPD's close of...
00:35 , Oct 4, 2011 |  BC Extra  |  Company News

PPD to go private in $3.9B deal

The Carlyle Group and Hellman & Friedman will take CRO PPD Inc. (NASDAQ:PPDI) private for $33.25 per share in cash, or $3.9 billion. The price is a 30% premium to PPD's close of $25.66 on...